No difference found in neural tube defects in HIV positive pregnancies
Surveillance programmes across the USA have estimated that the prevalence of neural tube defects (NTDs) in children born to mothers with HIV is 7.0 per 10,000 live births, essentially equal to that of general population.
This was the first time the CDC had linked both its birth defect surveillance & HIV surveillance programmes, allowing them to draw new inferences from existing data. Analysis of the data found no difference in NTD prevalence in pregnancies of HIV positive mothers with the rate being 7.0 per 10,000 live births, compared to 8.0 per live births in the general population.
3 veebruar 2020 18:42
Promising HIV vaccine trial discontinued
A promising clinical trial into a new HIV vaccine has been abandoned this week after it was found to be ineffective at preventing HIV.
The vaccine trial, known as HVTN 702, was being conducted by the HIV Vaccine Trials Network (HVTN) and sponsored by the ...
Lugege edasi
28 jaanuar 2020 11:26
Dispersible dolutegravir to improve HIV treatment for children
A new way to take HIV treatment could soon be on the cards for children living with HIV as ViiV Healthcare submits a new dispersible form of dolutegravir to the US Food and Drug Administration and the European Medicines Agency.
The new formulation, a tablet ...
Lugege edasi
Mis on Life4me+?
Üks Life4me+ peamiseid eesmärke on uute HIVi- ja muude sugulisel teel levivate nakkuste juhtumite, nagu ka C-hepatiiti ja tuberkuloosi nakatumise ennetamine. Seepärast räägime HIVist ja muudest haigustest — sellest, kuidas end nende eest kaitsta ja kuidas elada nakatununa.
Rohkem
Kampaania Life4me+
Info haridusliku kampaania "M = M" kohta ("Mittetuvastatav = mitteedasikanduv", #UequalsU, #НравноН), mis on Life4me+ poolt organiseeritud Ida-Euroopas ja Kesk-Aasias regioonis, suunatud info levitamisele, et HIV-positiivne inimene mittetuvastatava viiruskoormusega ei saa viirust seksuaalsel teel edasi kanda teisele inimesele.
Mitmed uuringud on näidanud, et diskordantses paaris, kus HIV-positiive partner võtab ARV ravimeid ja hoiab viiruskoormuse mittetuvastataval tasemel, ei ole teada juhtumitest, kus HIV oleks seksuaalsel teel edasi kandunud.
Meie partnerid
